Yew Bio Pharm Income Statement - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.33 $0 (0%) YEWB stock closing price Feb 24, 2017 (Closing)

Looking at financial statements, along with the Yew Bio Pharm stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis.   The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from $16.06M to $14.67M and how operating and non operating activities have impacted the YEWB stock. One also needs to look at Yew Bio Pharm assets, operating expenses and Yew Bio Pharm free cash flow. The profit and loss statement shows revenue of $14.67M for 2016-Q3. Revenue has decreased by $1.39M QoQ for YEWB stock. View details of revenue and profits for Yew Bio Pharm for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Yew Bio Pharm Net Sales or Revenues
14.67M16.06M8.62M17.27M5M4.67M2.64M1.9M1.7M2.06M
Cost Of Goods Sold (COGS)13.24M14.41M7.22M15.52M3.57M2.28M1.17M0.9M0.29M0.42M
Yew Bio Pharm Gross Profit
1.41M1.64M1.39M1.78M1.41M2.37M1.47M1.01M1.4M1.63M
Research & Development Expense----------
Selling General & Admin Expense0.29M0.34M0.31M0.46M0.48M0.48M0.47M0.41M0.51M0.22M
Income Before Depreciation Depletion Amortization1.11M1.3M1.07M1.32M0.93M1.89M0.99M0.61M0.89M1.41M
Depreciation Depletion Amortization----------
Non Operating Income-0.03M--0.02M0.05M-0.11M----
Interest Expense----------
Yew Bio Pharm Pretax Income
1.08M1.3M1.05M1.38M0.93M2M0.99M0.61M0.89M1.41M
Provision for Income Taxes----0.04M--0.04M---
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations1.08M1.31M1.05M1.39M0.93M2.01M0.96M0.61M0.89M1.41M
Extraordinary Items & Discontinued Operations----------
Yew Bio Pharm Net Income (Profit/Loss)
1.08M1.31M1.05M1.39M0.93M2.01M0.96M0.61M0.89M1.41M
Average Shares used to compute Diluted EPS51.89M51.88M51.88M51.88M52.19M57.62M58.23M---
Average Shares used to compute Basic EPS51.88M51.88M51.88M51.88M52.16M52.13M52.13M---
Income Before Nonrecurring Items1.08M1.31M1.05M1.39M0.93M2.01M0.96M---
Income from Nonrecurring Items----------
Yew Bio Pharm Earnings Per Share Basic Net
0.020.030.020.030.020.040.02---
Yew Bio Pharm Earnings Per Share Diluted Net
0.020.030.020.030.020.030.02---
EPS Diluted Before Nonrecurring Items0.020.030.020.030.020.030.02---
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

It is very helpful to read a report on Yew Bio Pharm stock analysis. An investor must check the following items in an income statement:
  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth (See: Yew Bio Pharm revenue chart) implies that the company is growing, which has not been the case with Yew Bio Pharm. One must stay away from stocks whose revenues are declining.
  • Bottom line: Most businesses like Yew Bio Pharm try to improve their bottom line by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Yew Bio Pharm historical stock prices to check how the price has moved with time. .

Yew Bio Pharm Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
3.3000
PS ratio (
price sales ratio
)
0.3024
Operating margin
7.6
Net profit margin
7.4
Dividend yield
0%

Other Income Statements - Yew Bio-Pharm Group, Inc. Industry Peers

Fibria Celulose income statement, Grow Solutions income statement, Pope Resources income statement